Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

“Molecular Assemblies is the original leader in enzymatic oligo synthesis, with strong foundational IP. Their team has made great strides in designing and developing an enzymatic DNA synthesis ...

Molecular Assemblies proprietary Fully Enzymatic SynthesisTM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business “Molecular ...

Molecular Assemblies proprietary Fully Enzymatic Synthesis TM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business SAN DIEGO--(BUSINESS ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

圣地亚哥 - 市值7.96亿美元的生命科学试剂和服务供应商Maravai LifeSciences, Inc. (NASDAQ: MRVI)宣布收购Molecular Assemblies, Inc.的知识产权和资产。根据 InvestingPro 数据，该公司保持强劲的流动性，流动比率为10.74，尽管面临近期挑战，过去十二个月收入下降34%。此次收购将增强Maravai子公司TriLink ...

When the constitutive components are molecules, the process is termed molecular self-assembly. The fabrication of circularly polarized luminescent (CPL) materials mostly rely on chemical and ...